• Piri Keşif Aracı

Arama ipuçları nelerdir?
1.  sayfa ve
1
Covid-19 COVID-19 Pandemic: An Unseen’s Evolution War
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Journal of Lumbini Medical College
Yazar(lar) :
Quek Yek Song , Michelle Jia Ni Ling
Yıl :
2020
Covid-19 COVID-19 Pandemic: An Unseen’s Evolution War Covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
This is a new beginning. It started just like a fiction movie. In December 2019, a new cluster of pneumonia caused by the 2019 novel coronavirus (2019-nCoV) was first identified in Wuhan, China. Without any mercy, it became a pandemic and left no time for grief. It was not only life-threatening but also challenged our healthcare system, economy, culture, lifestyle and belief. It forced us to make changes. We need to evolve, and we must evolve. Malaysia, a multi-ethnicity and multireligious country which is located in Southeast Asia, has a population of 32 million with a median age of 28.9 years in 2019. According to the Observatory of Economic Complexity, Malaysia has experienced rapid globalization and is the 19th leading exporter in the world. It is an upper-middle-income country with a gross domestic product (GDP) of 370 billion USD in 2019, of which 4.5% is funded to the healthcare system.
DOI : 10.22502/jlmc.v8i1.354
Anahtar Kelimeler : Covid-19, Malaysia, Social distancing
Cilt: 8
Sayı: 1
Sınıflandırma :
2
COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak 1:
Directory of Open Access Journals (DOAJ)
Kaynak 2:
Directory of Open Access Journals (DOAJ)
Dergi:
Revista Chilena de Anestesia
Yazar(lar) :
Mará Carolina Cabrera Schulmeyer
Yıl :
2020
COVID-19
Tam Metin
Kaydet Alıntıla
DOI : 10.25237/revchilanestv49n03.01
Cilt: 49
Sayı: 3
Sayfa: 305 - 305
3
COVID-19-associated encephalopathy: Neurological manifestation of COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Radiology Case Reports
Yazar(lar) :
Safaa Saeed Al Mazrouei , MBBS , Ghufran Aref Saeed , MBBS , Abeer Ahmed Al Helali , MBBS , Manzoor Ahmed , MBBS
Yıl :
2020
COVID-19-associated encephalopathy: Neurological manifestation of COVID-19 Coronavirus disease 2019 ( COVID- 19) is a viral disease, also known as severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China COVID- 19-associated neurological manifestations have not been widely reported. In this report, we describe a case of encephalopathy in a patient with COVID- 19 infection. Covid-19
Yayıncı Web Sitesi
Kaydet Alıntıla
Coronavirus disease 2019 (COVID-19) is a viral disease, also known as severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China, December 2019. Respiratory manifestations from the induced acute lung injury were the most common reported findings. Few cases showed extrapulmonary manifestations. COVID-19-associated neurological manifestations have not been widely reported. In this report, we describe a case of encephalopathy in a patient with COVID-19 infection.
Anahtar Kelimeler : Covid-19, coronavirus, RT-PCR, reverse transcription polymerase chain reaction, central nervous system, Encephalopathy
ISSN: 1930-0433
Cilt: 15
Sayı: 9
Sayfa: 1646 - 1649
Sınıflandırma :
4
COVID-19 solution
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
International Journal of Preventive Medicine
Yazar(lar) :
Roberto Menicagli , Mario Limodio
Yıl :
2020
COVID-19 solution Some CoVs have recently entered humans from infected animals and lastly we have SARS COVID- 19, (CoV), which causes severe acute, often fatal respiratory sars covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Coronaviruses (CoV) are RNA viruses that cause endemic infections in various species of mammals and avian birds. There are seven known human CoVs, each of which causes respiratory diseases: together account for about one third of common colds. Some CoVs have recently entered humans from infected animals and lastly we have SARS COVID-19, (CoV), which causes severe acute, often fatal respiratory syndromes. The prevalence of CoV, the easy zoonotic transmission and the potential to cause serious respiratory diseases, lead to urgent research to discover the mechanisms of CoV infection. Our study has identified a possible way to eliminate the danger of this virus by analyzing the structures by which it enters the host cell. This study indicates that the neuroaminidase interrupts the infection.
DOI : 10.4103/ijpvm.IJPVM_227_20
Anahtar Kelimeler : neuroaminidase, sars covid-19, sialic acid
Cilt: 11
Sayı: 1
Sayfa: 73 - 73
Sınıflandırma :
Viroloji %95
5
Why COVID-19?
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Advanced Journal of Emergency Medicine
Yazar(lar) :
Elnaz Vahidi , Mohammad Jalili
Yıl :
2020
Why COVID-19? Covid- 19 has been estimated to have a case fatality rate of around 3%. In late December 2019, an outbreak of COVID- 19 was reported from Wuhan city, China. Today COVID- 19 has affected more than 212 countries and has made billions of people to be quarantined in their houses.
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
COVID-19 is a highly contagious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), an enveloped positive stranded RNA virus and the third member of the family Coronaviridae which has emerged as a zoonotic infection. The predecessor of this new pathogen caused the Severe Acute Respiratory Syndrome (SARS) in 2003 and the Middle East Respiratory Syndrome (MERS) in 2012. Although corona viruses have been known since 1960’s, their familiar species were human pathogens and caused common cold and seasonal flu. SARS-CoV-2 is easily transmitted via respiratory secretions of an infected person, with a reproductive number (the average number of cases to which a single infected person will transmit the virus) of 1.4-2.5. Covid-19 has been estimated to have a case fatality rate of around 3%. As of today, asymptomatic transmission is assumed to be possible during the incubation period, which usually ranges from 2-14 days. The source of infection, animal host, and reservoir are currently unknown. In late December 2019, an outbreak of COVID-19 was reported from Wuhan city, China. The disease soon spread outside China borders and became rapidly prevalent all around the world. The pandemic announcement was officially made by World Health Organization (WHO) on 11 March 2020. Today COVID-19 has affected more than 212 countries and has made billions of people to be quarantined in their houses. Up to now, almost 1500000 confirmed cases of COVID-19 have been reported globally and the death toll has been declared to be 86000. In Iran, we are also facing this unprecedented global public health emergency, with about 65000 confirmed cases and 3993 deaths. This pandemic is beyond an expanding contagious disease and has influenced different features of life. Its enormous social, political, and specifically economic impacts all around the world are undeniable. In low- and middle-income countries this can potentially lead to a huge spike in poverty and collapse. Many vulnerable families have lost their income and access to the essential needs. Education systems have collapsed in many regions. The long-term effect of this global crisis has reduced economic growth even in developed countries. Economic effects of COVID-19 are estimated with dramatic variations. Orlik et al in Bloomberg hypothesized this cost to be $2.7 trillion. The political consequences are even harder to predict but quite significant and devastating, like the heated discussion, criticism and accusation flowing between the leaders of different countries. Since the pandemic is not yet over, the global influence will carry on to happen and make situation even more complicated. While the outbreak is evolving rapidly, health care systems across the world are actively fighting against the new virus. They have encountered many new challenges. Public health measures (such as active case finding, prompt isolation of cases and contacts tracing) to contain the spread of the disease in the society as well as provision of care for the unpredictably high number of people who are infected with the virus have stretched the healthcare system beyond its capacity. At the same time, protecting health care providers’ safety, which often requires provision of sufficient supplies of personal protective equipment, has definitely challenged the system. Societal demand for discovery of a definitive treatment and vaccine has also added to the complexity of the situation that the health care systems are facing. Studies about COVID-19 are increasingly being performed and published; many of them have not yet been fully reviewed and criticized by the academic community. Practitioners often find it difficult to find, appraise and apply the information they need amid the turbulence of their clinical practice. Furthermore, there are still many questions to be answered. The most efficient method for personal protection, methods of viral transmission, most accurate diagnostic approaches, and effective treatment options are yet to be determined. This special issue of the Advanced Journal of Emergency Medicine plans to specifically focus on COVID-19 by gathering the relevant scientific information available. We hope that by publishing high quality papers, this journal can provide its readers with further required information. Appropriate management of patients suffering COVID-19 as well as controlling this pandemic are our ultimate aspirations. We encourage further researches in this field by all scientists and physicians all across the world to be able to eradicate COVID-19 as soon as possible.
DOI : 10.22114/ajem.v0i0.402
ISSN: 2588-400X
Sınıflandırma :
Viroloji %77
6
Fighting COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Brazilian Journal of Biology
Yazar(lar) :
D. M. O. Campos , C. B. S. Oliveira , J. M. A. Andrade , J. I. N. Oliveira
Fighting COVID-19 Abstract The current COVID- 19 pandemic caused by the novel coronavirus (SARS-CoV2) poses a threat to global health owing to its high rate of spread and covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Abstract The current COVID-19 pandemic caused by the novel coronavirus (SARS-CoV2) poses a threat to global health owing to its high rate of spread and severe forms of respiratory infection. The lack of vaccines and antivirals prevents clinical strategies against the disease, creating an emerging need for the development of safe and effective treatments. Strategies for vaccine development include complete vaccines against viruses, subunits, and nucleic acids, but are still in their early stages. Studies carried out to date on possible SARS-CoV2 drug targets highlight glycoprotein S, Mpro (main protease or protease type 3C), and a member of the transmembrane serine protease II families (TMPRSS2). However, due to the pandemic state, priority is given to marketed drugs. These include chloroquine (CQ), hydroxychloroquine (HCQ), nitazoxanide, remdesivir, Lopinavir/ritonavir (LPV / r), in addition to treatment with convalescent plasma. But, therapeutic specific effects against SARS-CoV2 have not yet been verified. Most of the information obtained about treatment is based on preliminary and limited studies. We conclude that, at this time of emergency, the search for new therapies is more urgent due to the need to save lives. Thus, we point out as interesting targets for future more specific research: glycoprotein S, Mpro, and TMPRSS2.
DOI : 10.1590/1519-6984.238155
Anahtar Kelimeler : virology, sars-cov2, covid-19, infectious diseases
Sınıflandırma :
Biyotıp %100
Viroloji %99
7
COVID-19 reflections
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Research and Humanities in Medical Education
Yazar(lar) :
Dr Purvi Bhagat
Yıl :
2020
COVID-19 reflections
Yayıncı Web Sitesi
Kaydet Alıntıla
Anahtar Kelimeler : covid19, coronavirus, health humanities, medical humanities, poetry in medicine, pandemic
ISSN: 2350-0565
Cilt: 7
Sayfa: 100 - 101
Sınıflandırma :
8
Asymptomatic COVID-19 Infection Management: The Key to Stop COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Journal of Clinical and Experimental Investigations
Yazar(lar) :
Rachid Ait Addi , Abdelhafid Benksim , Mohamed Amine , Mohamed Cherkaoui
Yıl :
2020
Asymptomatic COVID-19 Infection Management: The Key to Stop COVID-19 The COVID- 19 disease, emerged in December 2019, has spread rapidly, with new cases confirmed in multiple countries. portion of the population to virus and increase the late diagnosis and thereafter enhance COVID- 19 mortality. Thereafter, it is fundamental to review our COVID- 19 screening approach and enlarge COVID- 19 testing to the general population by using rapid testing appliances COVID-19
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
The COVID-19 disease, emerged in December 2019, has spread rapidly, with new cases confirmed in multiple countries. Many efforts to contain the virus are ongoing, such as containment, individual measures of protection, the authorization of use of some drugs as chloquorine in some countries. Also, it has been known that symptomatic and asymptomatic people whom are infected by COVID-19 have the same contagiousness which expose a far greater portion of the population to virus and increase the late diagnosis and thereafter enhance COVID-19 mortality. Thereafter, it is fundamental to review our COVID-19 screening approach and enlarge COVID-19 testing to the general population by using rapid testing appliances such as rapid SARS-CoV-2 IgG-IgM combined antibody since another appliance more efficient will be performed.
DOI : 10.5799/jcei/7866
Anahtar Kelimeler : COVID-19, pandemic, screening, diagnosis
Cilt: 11
Sayı: 3
Sayfa:
Sınıflandırma :
9
Decolonising COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
The Lancet Global Health
Yazar(lar) :
The Lancet Global Health
Yıl :
2020
Decolonising COVID-19
Yayıncı Web Sitesi
Kaydet Alıntıla
ISSN: 2214-109X
Cilt: 8
Sayı: 5
Sayfa: e612
Sınıflandırma :
10
COVID-19: Immunopathogenesis
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
Yazar(lar) :
Deniz MAVİ , Ahmet Çağkan İNKAYA
Yıl :
2020
COVID-19: Immunopathogenesis Coronavirus- 19 disease ( COVID- 19) first described in Wuhan, China at the end of 2019. respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks may help to elucidate the pathogenesis of COVID - 19.
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
Coronavirus-19 disease (COVID-19) first described in Wuhan, China at the end of 2019. It spread rapidly all over the world and claimed the lives of over 300,000 people. There is no known effective vaccine and treatment yet. It is impossible to develop vaccines and specific treatment without understanding the pathogenesis of the disease. Experience from severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks may help to elucidate the pathogenesis of COVID-19. Nevertheless, many issues remained obscure regarding the pathogenesis of SARS-CoV-2. Exaggerated immune response leads to respiratory failure and even complications which may culminate in death. Cytokines storm, the complement system, endothelial damage, coagulation cascade, cellular and humoral immunity all play an important role in immune pathogenesis and inflammation. In this review, the relationship between the immune response/host characteristics of SARS-CoV-2 and the severity of the disease, antibody responses, and immune pathogenesis, possible causes of hypercoagulation will be discussed and it’s aimed to provide perspective on the development of effective vaccines and specific treatment.
DOI : 10.5578/flora.69606
Anahtar Kelimeler : sars-cov, sars-cov-2, immunopathogenesis, cytokine storm
ISSN: 1300-932X
Cilt: 25
Sayı: 2
Sayfa: 121 - 131
Sınıflandırma :
Viroloji %74
11
Forecasting COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Frontiers in Physics
Yazar(lar) :
Matjaž Perc , Matjaž Perc , Matjaž Perc , Nina Gorišek Miksić , Nina Gorišek Miksić , Mitja Slavinec , Andraž Stožer
Yıl :
2020
Forecasting COVID-19 COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
The World Health Organization declared the coronavirus disease 2019 a pandemic on March 11th, pointing to the over 118,000 cases in over 110 countries and territories around the world at that time. At the time of writing this manuscript, the number of confirmed cases has been surging rapidly past the half-million mark, emphasizing the sustained risk of further global spread. Governments around the world are imposing various containment measures while the healthcare system is bracing itself for tsunamis of infected individuals that will seek treatment. It is therefore important to know what to expect in terms of the growth of the number of cases, and to understand what is needed to arrest the very worrying trends. To that effect, we here show forecasts obtained with a simple iteration method that needs only the daily values of confirmed cases as input. The method takes into account expected recoveries and deaths, and it determines maximally allowed daily growth rates that lead away from exponential increase toward stable and declining numbers. Forecasts show that daily growth rates should be kept at least below 5% if we wish to see plateaus any time soon—unfortunately far from reality in most countries to date. We provide an executable as well as the source code for a straightforward application of the method on data from other countries.
DOI : 10.3389/fphy.2020.00127
Anahtar Kelimeler : COVID-19, pandemic, disease dynamics, exponential growth, virality
ISSN: 2296-424X
Cilt: 8
Sınıflandırma :
Ekonomi %21
Demografi %20
12
Pandemia COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Gazeta Médica
Yazar(lar) :
José Carlos Lopes Martins
Yıl :
2020
Pandemia COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Este é simultaneamente um tempo de combate e um tempo de preparação do pós-guerra. Estamos a defrontar um inimigo invisível e insidioso com um enorme potencial de destruição de saúde das populações e da economia dos Países, que coloca tremendos desafi os aos sistemas de saúde e às lideranças institucionais e políticas. A mobilização de respostas adequadas requer, como nunca, lideranças fortes e esclarecidas por parte de empresas, organizações sociais e decisores políticos porque está em causa um difícil trade-off entre saúde e economia que precisa de ser lidado com inteligência, coragem e perseverança; precisamos de sair destes estranhos e pesados dias com a força e os meios que nos permitam reconstituir as estruturas económicas e sociais abaladas por esta pandemia. Sem experiências anteriores sobre uma epidemia desta magnitude há que recorrer, desde logo, aos conhecimentos científicos disponíveis, que aliás têm estado a ser atualizados num notável esforço de investigação participada e partilhada entre os principais centros de investigação científi ca de todo o mundo. Mas há que recorrer também às competências de gestão deste tipo de crises, com envolvimento ativo de todas as forças sociais e económicas que sejam relevantes na dura luta que há que travar. É em momentos conturbados e difíceis como o que estamos a viver, que são imprescindíveis lideranças mobilizadoras capazes de obter o melhor das organizações e de nós todos, principalmente daqueles que têm que estar na primeira linha de combate - os Profi ssionais de saúde. É felizmente o que tem estado a ocorrer com organizações de saúde como é o caso da José de Mello Saúde que, atempadamente planeou e organizou os recursos de forma a contribuir responsavelmente para o esforço nacional que o País tem em curso. Esta, como outras grandes crises da humanidade, há de passar embora deixando um enorme impacto económico e social; preparemos com confi ança um futuro que será com certeza mais incerto e mais exigente.
DOI : 10.29315/gm.v7i1.312
Cilt: 7
Sayı: 1
13
COVID-19: rethinking risk
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
The Lancet Global Health
Yazar(lar) :
Nina Schwalbe , Susanna Lehtimaki , Juan Pablo Gutiérrez
Yıl :
2020
COVID-19: rethinking risk
Yayıncı Web Sitesi
Kaydet Alıntıla
ISSN: 2214-109X
Cilt: 8
Sayı: 8
Sayfa: e974 - e975
Sınıflandırma :
14
COVID 19: Neuromuscular manifestations
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Annals of Indian Academy of Neurology
Yazar(lar) :
Rajesh Benny , Satish V Khadilkar
Yıl :
2020
COVID 19: Neuromuscular manifestations COVID- 19 pandemic is ongoing and information on the neurological aspects of this viral infection is being gathered. This manuscript studies the available information on the neuromuscular manifestations of COVID- 19. covid-19 neurological manifestations covid-19 neuromuscular manifestations
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
COVID-19 pandemic is ongoing and information on the neurological aspects of this viral infection is being gathered. Neuromuscular manifestations have been reported uncommonly in these early stages of the analysis. This manuscript studies the available information on the neuromuscular manifestations of COVID-19.
DOI : 10.4103/aian.AIAN_309_20
Anahtar Kelimeler : covid-19 neurological manifestations, covid-19 neuromuscular manifestations, guillain barre syndrome, myositis
Cilt: 23
Sayı: 7
Sayfa: 40 - 42
Sınıflandırma :
Viroloji %27
15
COVID-19 in Brazil
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Pulmonology
Yazar(lar) :
F.A.L. Marson , M.M. Ortega
Yıl :
2020
COVID-19 in Brazil
Yayıncı Web Sitesi
Kaydet Alıntıla
Cilt: 26
Sayı: 4
Sayfa: 241 - 244
16
COVID-19 and hypertension
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Journal of the Renin-Angiotensin-Aldosterone System
Yazar(lar) :
Spoorthy Kulkarni , Bernadette L. Jenner , Ian Wilkinson
Yıl :
2020
COVID-19 and hypertension
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : 10.1177/1470320320927851
Cilt: 21
Sınıflandırma :
17
Cannabinoids and COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Medical Cannabis and Cannabinoids
Yazar(lar) :
Myriam El Biali , Barbara Broers , Marie Besson , Jules Demeules
Yıl :
2020
Cannabinoids and COVID-19 involved in immune function, the effect of cannabinoid intake on infectious conditions is questioned for several years and is of particular interest in the COVID 19 pandemia. covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Since the endocannabinoid system is involved in immune function, the effect of cannabinoid intake on infectious conditions is questioned for several years and is of particular interest in the COVID 19 pandemia. Some data suggest that the immunomodulatory effect of cannabinoids may affect the course and severity of SARS-CoV-2 infection. Given the large number of cannabinoids consumers in the community, this commentary presents the current knowledge on the potential impact of cannabinoids and endocannabinoids on bacterial and viral infection courses namely SARS-CoV-2 disease. Practical recommendations, which can be drawn from the literature, are given.
DOI : 10.1159/000510799
Anahtar Kelimeler : sars-cov-2, covid-19, immunity, cannabinoids, endocannabinoid system
ISSN: 2504-3889
Sayfa: 1 - 5
Sınıflandırma :
18
Epidemiology of COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak 1:
Directory of Open Access Journals (DOAJ)
Kaynak 2:
Directory of Open Access Journals (DOAJ)
Dergi:
Journal of Digestive Endoscopy
Yazar(lar) :
Sudipta Dhar Chowdhury , Anu Mary Oommen
Yıl :
2020
Epidemiology of COVID-19 COVID- 19, an infectious respiratory illness caused by the severe acute respiratory syndrome–corona virus 2 (SARS-CoV2), has now spread to multiple countries This review of the epidemiology of COVID- 19 summarizes the burden of infection, transmission dynamics, and other related epidemiological features. Delivering health care for both COVID- 19 affected individuals, as well those with other acute and chronic conditions, with limited access to healthcare covid-19
Piri Tam Metin Bulucu
Kaydet Alıntıla
COVID-19, an infectious respiratory illness caused by the severe acute respiratory syndrome–corona virus 2 (SARS-CoV2), has now spread to multiple countries including India. The pace at which the disease spread in the last 4 months, since it was first recognized from China, is unprecedented. This review of the epidemiology of COVID-19 summarizes the burden of infection, transmission dynamics, and other related epidemiological features. While countries such as China, Italy, and the United States have particularly high-rates of infection, the disease is gradually spreading in India as well, threatening the health and economy of the country. Transmission in asymptomatic cases, early symptomatic phase, as well as limited access to testing in different settings are factors that have led to the rapid spread of infection. A large case series from China revealed that 81% of cases had mild symptoms, 14% had severe disease, and 5% were afflicted with critical illness. While the mortality in China was reported as 2.3%, Italy, with a high-proportion of elderly, reported a case fatality report of 7.2% due to higher infection and mortality rates among the elderly. Being a highly infectious disease, with a basic reproduction number between 2 to 3, COVID-19 is affecting a large number of healthcare workers, as evidenced by the fact that a sizeable portion of reported infections in the US included healthcare workers. Delivering health care for both COVID-19 affected individuals, as well those with other acute and chronic conditions, with limited access to healthcare facilities and services, are challenges for the health systems in low- and middle-income countries, which require immediate measures for health system strengthening across sectors.
DOI : 10.1055/s-0040-1712187
Anahtar Kelimeler : covid-19, coronavirus, epidemiology, pandemic, sars-cov2
Cilt: 11
Sayı: 01
Sayfa: 03 - 07
Sınıflandırma :
19
Pharmacists and COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Journal of Pharmaceutical Policy and Practice
Yazar(lar) :
Ali Elbeddini , Thulasika Prabaharan , Sarah Almasalkhi , Cindy Tran
Yıl :
2020
Pharmacists and COVID-19 Abstract In the fight against COVID- 19, frontline health workers have been vital to keeping the pandemic at bay, but recognition of individual professions - 19 treatments, and contributing to COVID- 19 screening. Amid COVID- 19, pharmacists have not stopped working as frontline workers and they should be recognized as such. COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Abstract In the fight against COVID-19, frontline health workers have been vital to keeping the pandemic at bay, but recognition of individual professions’ efforts have been inconsistent at all levels. Pharmacists around the world have continued to provide direct patient care and perform frontline duties for their communities during this pandemic, but are often relegated to the background and overlooked when frontline workers are heralded. Community pharmacists are the most accessible healthcare practitioners, which is further proven during the pandemic as they continued to provide direct patient care despite restrictions imposed by the government due to the pandemic. Due to the inaccessibility of other healthcare practitioners during this time, community pharmacists have reduced the burden on the healthcare system by diverting the influx of patients away from hospitals through triaging and screening patients. Community pharmacists have played various roles in supporting the healthcare system during COVID-19: delivering medications to patients, educating patients on telehealth services, assessing patients for renewal of chronic medications, performing consultations on minor ailments, clarifying misconceptions about COVID-19 treatments, and contributing to COVID-19 screening. Alongside ICU nurses, physicians, and respiratory therapists, hospital pharmacists have been part of the COVID-19 efforts and their roles include management of drug shortages, development of treatment protocols, participation of patient rounds, interpretation of lab results for COVID-19, participant recruitment for clinical trials, exploration of new drugs, medication management advice, and antimicrobial stewardship. Further support from pharmacists will be needed once a vaccine is launched in order to reach population-wide coverage. Amid COVID-19, pharmacists have not stopped working as frontline workers and they should be recognized as such.
DOI : 10.1186/s40545-020-00241-3
Anahtar Kelimeler : Frontline health workers, Pharmacist, COVID-19, Pandemic
ISSN: 2052-3211
Cilt: 13
Sayı: 1
Sayfa: 1 - 4
Sınıflandırma :
20
Post-COVID-19 spending
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
The Lancet Planetary Health
Yazar(lar) :
The Lancet Planetary Health
Yıl :
2020
Post-COVID-19 spending
Yayıncı Web Sitesi
Kaydet Alıntıla
ISSN: 2542-5196
Cilt: 4
Sayı: 5
Sayfa: e168
Sınıflandırma :
21
AIDE-MEMOIRE COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Global Journal of Transfusion Medicine
Yıl :
2020
AIDE-MEMOIRE COVID-19
Yayıncı Web Sitesi
Kaydet Alıntıla
Cilt: 5
Sayı: 1
Sayfa: 7 - 8
Sınıflandırma :
22
Comorbidities and COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Journal of Anaesthesiology Clinical Pharmacology
Yazar(lar) :
Lakshmi Narayana Yaddanapudi
Yıl :
2020
Comorbidities and COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : 10.4103/joacp.JOACP_305_20
Cilt: 36
Sayı: 5
Sayfa: 18 - 20
Sınıflandırma :
23
Tobacco and COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Eurasian Journal of Pulmonology
Yazar(lar) :
Ozlem Sonmez , Zeynep Atam Taşdemir , H Volkan Kara , Sule Akçay
Yıl :
2020
Tobacco and COVID-19 Similar data have been approved found for coronavirus disease-2019 ( COVID- 19) pandemic. adverse effects of tobacco and tobacco products and to raise awareness among the public and to make efforts to smoking on every opportunity during the COVID - 19 pandemic. covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Tobacco and its products are the well-known causes of premature deaths associated with cancer, cardiovascular disease, and chronic obstructive pulmonary disease, as well as they constitute a significant risk factor that increases the tendency to respiratory system infection and other systemic infections. Active tobacco use and passive smoking increase the risk of infection. Both increase peribronchial and alveolar inflammation and fibrosis and mucosal permeability, cause inadequate mucociliary cleaning, damage to the respiratory tract epithelium resulting in fibrosis, and they adversely affect cellular and humoral immunity. Smoking has been known to increase the risk for viral infections and influenza. Similar data have been approved found for coronavirus disease-2019 (COVID-19) pandemic. Smoking is reported to be associated with the frequency of the disease and its severity of the clinical course. Severe acute respiratory syndrome-coronavirus-2 penetrates the cell using the angiotensin-converting enzyme 2 receptors. Such receptor proteins had been shown to increase in smoker individuals. Also, smoking facilitates penetration of the virus into the cell. The frequency of smoking and the rates of admission to intensive care, mechanical ventilation, and mortality have been also found to be higher was higher in severe cases. The risk for disease progression was found to be 14-fold higher in smokers. Further, the World Health Organization emphasized similar negative effects of hookah and new tobacco products such as electronic cigarettes and heated tobacco products. It is vital to underline the adverse effects of tobacco and tobacco products and to raise awareness among the public and to make efforts to smoking on every opportunity during the COVID-19 pandemic. Public awareness campaigns during the pandemic must always accompanied by the methods and strategies to avoid active and passive smoking.
DOI : 10.4103/ejop.ejop_52_20
Anahtar Kelimeler : covid-19, sars-cov-2, smoking, tobacco use
Cilt: 22
Sayı: 4
Sayfa: 12 - 15
Sınıflandırma :
24
COVID-19: a review
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Monaldi Archives for Chest Disease
Yazar(lar) :
Irappa Madabhavi , Malay Sarkar , Nagaveni Kadakol
Yıl :
2020
COVID-19: a review The enduring epidemic outbreak which started in Wuhan city of China, in December 2019 caused by the 2019 novel coronavirus ( COVID- 19) or the severe acute A highly virulent and pathogenic COVID- 19 viral infection with incubation period ranging from two to fourteen days, transmitted by breathing of infected Approximately 1,016,128 reported cases, 211,615 recovered cases and 53,069 deaths of COVID-2019 have been reported to date (April 2, 2020). COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
The enduring epidemic outbreak which started in Wuhan city of China, in December 2019 caused by the 2019 novel coronavirus (COVID- 19) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created a dangerous and deadly Public Health disaster of International apprehension, with cases confirmed in several countries. This novel community health trouble is frightening the universe with clinical, psychological, emotional, collapse of health system and economical slowdown in each and every part of the world infecting nearly 200 countries. A highly virulent and pathogenic COVID-19 viral infection with incubation period ranging from two to fourteen days, transmitted by breathing of infected droplets or contact with infected droplets, belongs to the genus Coronavirus with its high mutation rate in the Coronaviridae. The likely probable primary reservoir could be bats, because genomic analysis discovered that SARSCoV-2 is phylogenetically interrelated to SARS-like bat viruses. The transitional resource of origin and transfer to humans is not known, however, the rapidly developing pandemic has confirmed human to human transfer. Approximately 1,016,128 reported cases, 211,615 recovered cases and 53,069 deaths of COVID-2019 have been reported to date (April 2, 2020). The symptoms vary from asymptomatic, low grade pyrexia, dry cough, sore throat, breathlessness, tiredness, body aches, fatigue, myalgia, nausea, vomiting, diarrhea, to severe consolidation and pneumonia, acute respiratory distress syndrome (ARDS) and multiple organ dysfunction leading to death with case fatality rate ranging from 2 to 3%.
DOI : 10.4081/monaldi.2020.1298
Anahtar Kelimeler : Coronavirus, COVID-19, outbreak, infection, pneumonia
Cilt: 90
Sayı: 2
Sınıflandırma :
25
Coagulopathy and COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Eurasian Journal of Pulmonology
Yazar(lar) :
Onur Yazici , Fulsen Bozkuş , Nilgün Demirci , Pınar Yıldız Gülhan , Funda Coşkun
Yıl :
2020
Coagulopathy and COVID-19 Caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), coronavirus disease 2019 ( COVID- 19) is a potentially fatal disease as a global The aim of this article is to review the potential mechanisms of coagulopathy in COVID- 19 in light of literature data. covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), coronavirus disease 2019 (COVID-19) is a potentially fatal disease as a global public health issue. Several mechanisms may be involved in mortality. One of these is coagulopathy and disseminated intravascular coagulation caused by SARS-CoV-2. When patients have coagulation disorders, treatment becomes more challenging and mortality rate increases accordingly. The aim of this article is to review the potential mechanisms of coagulopathy in COVID-19 in light of literature data.
DOI : 10.4103/ejop.ejop_49_20
Anahtar Kelimeler : covid-19, coagulopathy, disseminated intravascular coagulation
Cilt: 22
Sayı: 4
Sayfa: 67 - 69
Sınıflandırma :
26
Pathogenesis of COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak 1:
Directory of Open Access Journals (DOAJ)
Kaynak 2:
Directory of Open Access Journals (DOAJ)
Dergi:
Eurasian Journal of Pulmonology
Yazar(lar) :
Evrim Eylem Akpinar
Yıl :
2020
Pathogenesis of COVID-19 The coronavirus disease 2019 ( COVID- 19) is a very contagious infectious disease which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV The aim of this report is to review the immunopathogenesis of COVID- 19 in the light of current literature. covid-19
Piri Tam Metin Bulucu
Kaydet Alıntıla
The coronavirus disease 2019 (COVID-19) is a very contagious infectious disease which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus is first identified in Wuhan city of China in December 2019 and in a short time dispersed to rest of the World. Animal to human transmission of the virus happened by eating of an infected animal and then the virus is transmitted to healthy persons by close contact. Coronaviruses attach and enter to the host cells by means of the spikes on the cell membrane. The type 2 pneumocytes are the primary target of the virus. The aim of this report is to review the immunopathogenesis of COVID-19 in the light of current literature.
DOI : 10.4103/ejop.ejop_54_20
Anahtar Kelimeler : coronavirus, covid-19, pathogenesis
Cilt: 22
Sayı: 4
Sayfa: 8 - 11
Sınıflandırma :
Viroloji %88
27
COVID-19: Apocalypse Now?
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Journal of Cellular and Molecular Anesthesia
Yazar(lar) :
Ali Dabbagh
Yıl :
2020
COVID-19: Apocalypse Now?
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : 10.22037/jcma.v5i1.29845
Cilt: 5
Sayı: 1
Sayfa: 1 - 2
Sınıflandırma :
28
COVID-19 and globalization
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
One Health
Yazar(lar) :
Santiago Mas-Coma , Malcolm K. Jones , Aileen M. Marty
Yıl :
2020
COVID-19 and globalization
Yayıncı Web Sitesi
Kaydet Alıntıla
ISSN: 2352-7714
Cilt: 9
Sayfa:
Sınıflandırma :
29
COVID-19 in children
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Eurasian Journal of Pulmonology
Yazar(lar) :
Zeynep Reyhan Onay , Tuğba Şişmanlar Eyüboğlu , Ayşe Tana Aslan
Yıl :
2020
COVID-19 in children Coronavirus disease-2019 ( COVID- 19) has affected nearly 2 million people and caused up to 100,000 people death worldwide until today. It should be kept in mind that COVID- 19 may cause severe illness in infants under 1 year old and in children with chronic diseases such as chronic kidney Fever and cough are the most common symptoms in COVID- 19, and children can also be asymptomatic. Laboratory findings are variable in children.
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Coronavirus disease-2019 (COVID-19) has affected nearly 2 million people and caused up to 100,000 people death worldwide until today. This severe disease has seen less in children than adults. This may be due to the fact that cytokine storm in children is milder, viral load exposure is less than in adults, and angiotensin converting enzyme receptor levels are different from adults. It should be kept in mind that COVID-19 may cause severe illness in infants under 1 year old and in children with chronic diseases such as chronic kidney disease undergoing dialysis, sickle cell disease, chronic liver disease, endocrine disorders, chronic lung disease, cardiovascular disease, immune deficiency, and severe obesity. Fever and cough are the most common symptoms in COVID-19, and children can also be asymptomatic. Laboratory findings are variable in children. Ground-glass opacity, consolidation, patchy shadowing, halo sign, and interstitial anomalies can be detected in lung computed tomography, or it can be normal. In this review, the frequency of COVID-19 in children, differences between adults, the course of pregnancy and newborn, clinical and laboratory findings, and treatment options are reviewed.
DOI : 10.4103/ejop.ejop_51_20
Anahtar Kelimeler : children, coronavirus disease-2019, newborn, pregnancy
Cilt: 22
Sayı: 4
Sayfa: 82 - 89
Sınıflandırma :
30
Covid-19 and Neurology
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Türk Nöroloji Dergisi
Yazar(lar) :
Şerefnur Öztürk
Yıl :
2020
Covid-19 and Neurology Coronavirus disease- 19 ( COVID- 19) pandemic is a new and important burden for the neurological area. mechanisms of neurological involvement of the disease may be explained more efficiently by neurologists who are included within the multidisciplinary COVID - 19 teams. covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Neurological diseases are the most common and important health burden over the world. Coronavirus disease-19 (COVID-19) pandemic is a new and important burden for the neurological area. Information related to the neurological involvement of Severe Acute Respiratory syndrome-Coronavirus-2 infection has been increased during the last several months. Frequency and mechanisms of neurological involvement of the disease may be explained more efficiently by neurologists who are included within the multidisciplinary COVID-19 teams. Other very important point is possibility of failure of follow up and treatment of chronic neurological disorders which needed frequent and regular control and also quick action for the acute treatment. The regulations are extremely important for the neurologists to perform their responsibilities with considering all these requirements.
DOI : 10.4274/tnd.2020.73384
Anahtar Kelimeler : covid-19, neurology, turkey
Cilt: 26
Sayı: 2
Sayfa: 109 - 111
Sınıflandırma :
31
Astma and COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Eurasian Journal of Pulmonology
Yazar(lar) :
Zeynep Ferhan Ozseker
Yıl :
2020
Astma and COVID-19 Asthma represents no increased risk in terms of catching the coronavirus disease-2019 ( covid- 19), and no report has been published to date associating Covid- 19, as with all other respiratory infections, interferes with control of asthma. In conclusion, covid- 19 does not constitute a greater risk to patients with asthma.
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Humanity encountered a coronavirus (severe acute respiratory syndrome-coronavirus-2 (sars-cov-2)) pandemic on december 31, 2019 that is threatening the human race. The disease was first identified in the city of wuhan in china. It causes widespread pneumonia in the lungs, with the most significant laboratory findings being lymphopenia and eosinopenia in the blood count and elevated c-reactive protein and d-dimer. The findings increase with the progression of the clinical picture. Comorbidities in an individual determine the course of the disease, with the most important risk factors among those indicating a severe course being hypertension, ischemic heart disease, diabetes and chronic obstructive pulmonary disease. Asthma represents no increased risk in terms of catching the coronavirus disease-2019 (covid-19), and no report has been published to date associating its risk with a more severe disease course. Covid-19, as with all other respiratory infections, interferes with control of asthma. It is important to keep asthma under control during this period, as always. Patients should not stop taking their inhaled steroids, nor should they reduce the dose. Similarly, systemic steroids should not be stopped if prescribed to keep asthma under control. The use of anti-ige, anti il-5/il-5 alpha and anti il-4 alpha does not increase the risk of contracting covid-19, and these drugs may also be used to maintain asthma under control. A “to do” list should be provided to patients by their physicians as an action plan in the event of a worsening of asthma symptoms. Patients with allergic rhinitis can safely use their nasal steroid and antihistaminic drugs. Hand disinfectants that contain chlorhexidine may cause asthma attacks, and are not active against sars-cov-2. Using latex gloves to ensure hand hygiene may also lead to asthma attacks in individuals with a latex allergy. Washing the hands with water and soap should be preferred rather than using gloves. In conclusion, covid-19 does not constitute a greater risk to patients with asthma. Inhaled steroids and systemic steroids that keep the asthma under control can be used safely. Lowering a step in the treatment of asthma is not recommended in this period.
DOI : 10.4103/ejop.ejop_48_20
Anahtar Kelimeler : allergy, asthma, coronavirus disease-2019, severe acute respiratory syndrome-coronavirus-2
Cilt: 22
Sayı: 4
Sayfa: 52 - 55
Sınıflandırma :
32
COVID-19 and epilepsy
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Annals of Indian Academy of Neurology
Yazar(lar) :
Sora Yasri , Viroj Wiwanikit
Yıl :
2020
COVID-19 and epilepsy
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : 10.4103/aian.AIAN_254_20
Cilt: 23
Sayı: 7
Sayfa: 43 - 43
Sınıflandırma :
33
Coping with COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Journal of Lumbini Medical College
Yazar(lar) :
Bhagavat Nepal , Prof
Yıl :
2020
Coping with COVID-19 Antivirals, specifically Remdesivir has been a strong candidate for the treatment of COVID- 19. However, it has yet to receive universal acceptance for the treatment of COVID- 19. These findings suggest the hypothesis that anti-malarial drugs have efficacy in the treatment of COVID- 19. COVID 19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Severe acute respiratory syndrome corona virus (SARS-CoV-2) virus made its first appearance in Wuhan, China in December 2019. It has since spread like a wild fire across the globe with over five million corona virus disease (COVID-19) confirmed cases and almost three hundred fifty thousand deaths at the time of writing this article. This could however be only the tip of the iceberg considering the contagious nature of the SARS-CoV-2 virus and the rate at which it is spreading across the globe. China did well to contain the virus with strict lockdown measures, sealing the affected areas, active case finding, tracing, tracking and treating the COVID-19 cases at an astonishing speed. In the absence of specific treatment available as yet, treatment consists of mainly symptomatic management with some experimental medications. Antivirals, specifically Remdesivir has been a strong candidate for the treatment of COVID-19. However, it has yet to receive universal acceptance for the treatment of COVID-19. Chloroquine and Hydroxychloroquine seem to be effective in limiting the replication of SARS-CoV-2 virus in vitro. COVID-19 is highly pandemic in countries where malaria is least prevalent and least pandemic in countries where malaria is highly prevalent. These findings suggest the hypothesis that anti-malarial drugs have efficacy in the treatment of COVID-19.
DOI : 10.22502/jlmc.v8i1.355
Anahtar Kelimeler : COVID 19
Cilt: 8
Sayı: 1
Sınıflandırma :
34
COVID-19 Tapuya Reflection
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Tapuya
Yazar(lar) :
Raquel Velho
Yıl :
2020
COVID-19 Tapuya Reflection
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : 10.1080/25729861.2020.1781372
ISSN: 2572-9861
Sayfa: 1 - 1
35
Smoking and COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Vojnosanitetski Pregled
Yazar(lar) :
Igić Rajko
Yıl :
2020
Smoking and COVID-19
Yayıncı Web Sitesi
Tam Metin
Kaydet Alıntıla
DOI : 10.2298/VSP2005461I
Cilt: 77
Sayı: 5
Sayfa: 461 - 462
36
Resiliencia y Covid 19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Revista Colombiana de Obstetricia y Ginecología
Yazar(lar) :
Armando Solano Gámez
Yıl :
2020
Resiliencia y Covid 19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : 10.18597/rcog.3531
Cilt: 71
Sayı: 1
37
COVID-19 and publishing
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Science Editing
Yazar(lar) :
Kihong
Yıl :
2020
COVID-19 and publishing
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : 10.6087/kcse.203
Cilt: 7
Sayı: 2
Sayfa: 109 - 110
Sınıflandırma :
38
Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Vaccines
Yazar(lar) :
Jiahao Wang , Rize Jing , Xiaozhen Lai , Haijun Zhang , Yun Lyu , Maria Deloria Knoll , Hai Fang
Yıl :
2020
Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China Background: Faced with the coronavirus disease 2019 ( COVID- 19) pandemic, the development of COVID- 19 vaccines has been progressing at an unprecedented of vaccines against COVID- 19 during the pandemic. - 19 vaccination or valuing doctor’s recommendations could increase the probability of accepting COVID- 19 vaccination as soon as possible, while having COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Background: Faced with the coronavirus disease 2019 (COVID-19) pandemic, the development of COVID-19 vaccines has been progressing at an unprecedented rate. This study aimed to evaluate the acceptance of COVID-19 vaccination in China and give suggestions for vaccination strategies and immunization programs accordingly. Methods: In March 2020, an anonymous cross-sectional survey was conducted online among Chinese adults. The questionnaire collected socio-demographic characteristics, risk perception, the impact of COVID-19, attitudes, acceptance and attribute preferences of vaccines against COVID-19 during the pandemic. Multivariate logistic regression was performed to identify the influencing factors of vaccination acceptance. Results: Of the 2058 participants surveyed, 1879 (91.3%) stated that they would accept COVID-19 vaccination after the vaccine becomes available, among whom 980 (52.2%) wanted to get vaccinated as soon as possible, while others (47.8%) would delay the vaccination until the vaccine’s safety was confirmed. Participants preferred a routine immunization schedule (49.4%) to emergency vaccination (9.0%) or either of them (41.6%). Logistic regression showed that being male, being married, perceiving a high risk of infection, being vaccinated against influenza in the past season, believing in the efficacy of COVID-19 vaccination or valuing doctor’s recommendations could increase the probability of accepting COVID-19 vaccination as soon as possible, while having confirmed or suspected cases in local areas, valuing vaccination convenience or vaccine price in decision-making could hinder participants from immediate vaccination. Conclusion: During the pandemic period, a strong demand for and high acceptance of COVID-19 vaccination has been shown among the Chinese population, while concerns about vaccine safety may hinder the promotion of vaccine uptake. To expand vaccination coverage, immunization programs should be designed to remove barriers in terms of vaccine price and vaccination convenience, and health education and communication from authoritative sources are important ways to alleviate public concerns about vaccine safety.
DOI : 10.3390/vaccines8030482
Anahtar Kelimeler : SARS-CoV-2, COVID-19, immunization, vaccine acceptance, vaccine preference
ISSN: 2076-393X
Cilt: 8
Sayı: 482
Sayfa: 482
Sınıflandırma :
39
Stand on the Same Side Against Covid – 19 Clinical Management of Covid-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Substantia
Yazar(lar) :
Lorenzo Corbetta , Leonardo M. Fabbri , Shiyue Li , Jing Li , Bin Cao , Jin Yang , Giancarlo Agnelli , Michela Giustozzi , Alberto Mantovani , Luigi Camporota , Semra Bilaçeroğlu , Adrian Rendon
Yıl :
2020
Stand on the Same Side Against Covid – 19 Clinical Management of Covid-19 Covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
This document is the direct transcription of a Webinar organized by Prof. L. Corbetta of the University of Florence on May 29th, 2020.
DOI : 10.13128/Substantia-1022
Anahtar Kelimeler : Covid-19, Clinical Management, LOTUS China Trial, Lopinavir, Ritonavir, Wuhan
ISSN: 2532-3997
Cilt: 4
Sayı: 1
Sınıflandırma :
40
COVID-19 Case Management
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
South Sudan Medical Journal
Yazar(lar) :
Ruot Garjiek Teny , Charles O. C. Langoya , Ader Macar Aciek
Yıl :
2020
COVID-19 Case Management Coronavirus disease ( COVID- 19) was first reported to the World Health Organization (WHO) on 31 December 2019 from Wuhan province of China as a cluster COVID- 19 is caused by SARS-CoV-2 virus which is a member of coronaviruses.
Yayıncı Web Sitesi
Kaydet Alıntıla
Coronavirus disease (COVID-19) was first reported to the World Health Organization (WHO) on 31 December 2019 from Wuhan province of China as a cluster of pneumonia cases. The WHO on 11 March 2020 declared this as a global pandemic. COVID-19 is caused by SARS-CoV-2 virus which is a member of coronaviruses. South Sudan has 35 confirmed cases by 30 April 2020 with the first case announced on 4 April, 2020 while the last case (of the 35) declared on 29 April 2020.
Cilt: 13
Sayı: 2
Sayfa: 37 - 39
Sınıflandırma :
41
COVID-19 Neurological Manifestations
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
International Clinical Neuroscience Journal
Yazar(lar) :
Arash Azhideh
Yıl :
2020
COVID-19 Neurological Manifestations
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : 10.34172/icnj.2020.01
Cilt: 7
Sayı: 2
Sayfa: 54 - 54
42
COVID-19 and Indonesia
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Acta Medica Indonesiana
Yazar(lar) :
Siti Setiati , Muhammad Khifzhon Azwar
Yıl :
2020
COVID-19 and Indonesia Coronavirus disease 2019 ( COVID- 19) pandemic is an ongoing problem in more than 200 countries in the world. Indonesia has been greatly affected by COVID- 19 with case fatality rate (CFR) being 8.9% in the end of March 2020. Demand of health system is likely to grow since the number of COVID- 19 case is likely to rise. covid-19
Yayıncı Web Sitesi
Kaydet Alıntıla
Coronavirus disease 2019 (COVID-19) pandemic is an ongoing problem in more than 200 countries in the world. Indonesia has been greatly affected by COVID-19 with case fatality rate (CFR) being 8.9% in the end of March 2020. We have some room for improvement related to the unreadingess of healthcare facility and the major steps taken by the government. It is suggested that the country should have stricter Stay-at-Home notice, suppress the spread by imposing lockdown on a large scale, improve healthcare service, and increase the availability of personal protective equipments (PPE). It is important to avoid an epidemic peak that potentially overwhelms healthcare service by quarantining the case contacts. Lockdown may prolong the epidemic doubling time significantly. Demand of health system is likely to grow since the number of COVID-19 case is likely to rise. Effective procedures for protecting medical staff from infection are essential. Scientific research in Indonesia is also crucial to provide suggestion and recommendation pertinent to COVID-19.
Anahtar Kelimeler : covid-19, sars-cov-2, coronavirus, indonesia
Cilt: 52
Sayı: 1
Sınıflandırma :
43
More eyes on COVID-19: Perspectives from Philosophy: How philosophy bears on COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
South African Journal of Science
Yazar(lar) :
Thaddeus Metz
Yıl :
2020
More eyes on COVID-19: Perspectives from Philosophy: How philosophy bears on COVID-19 COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : 10.17159/sajs.2020/8494
Anahtar Kelimeler : COVID-19, humanities, philosophy, ethics, epistemology
Cilt: 116
Sayı: 7/8
Sınıflandırma :
Felsefe %68
44
The dilemma of being non COVID-19 hospital in the era of COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Indian Journal of Anaesthesia
Yazar(lar) :
Swati Singh
Yıl :
2020
The dilemma of being non COVID-19 hospital in the era of COVID-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : 10.4103/ija.IJA_489_20
Cilt: 64
Sayı: 14
Sayfa: 150 - 150
Sınıflandırma :
45
COVID 19: Relationship of the epidemiological pattern of COVID-19 between China and Italy
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Research, Society and Development
Yazar(lar) :
Camilla Mandarine Ferreira , Denyse Diomedes Constantino de Almeida , Manuela Lavareda Ayres Drummond de Mattos , Tharcia Kiara de Beserra de Oliveira
Yıl :
2020
COVID 19: Relationship of the epidemiological pattern of COVID-19 between China and Italy The study aimed to analyze the epidemiological pattern of COVID- 19 between Italy and China. The question that guided the review was: What were the epidemiological factors that led to the expression of COVID- 19 between China and Italy? Further, more in-depth studies are needed regarding the harmful effects of chronic diseases as risk factors for COVID- 19 infection.
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
The study aimed to analyze the epidemiological pattern of COVID-19 between Italy and China. The question that guided the review was: What were the epidemiological factors that led to the expression of COVID-19 between China and Italy? The search for the articles was carried out in April 2020 in the following databases: Scielo, Pubmed, VHL, ScienceDirect and Medline, using the following keywords: Coronavirus infections, epidemiology and risk factors. Studies show notable differences in the mortality rate between Asian and European populations. Three risk factors for worsening due to COVID-19 were listed: male gender, advanced age (older than 60 years) and the presence of comorbidities, especially chronic ones. Such factors were predominant mainly in Italy, compared to China. Hypertension, diabetes, cardiovascular diseases and cerebrovascular diseases are considered to be significant risk factors for COVID-19 and its worsening. Studies show that for both countries, being elderly and male increases the risk of contracting the disease in its most severe form. Further, more in-depth studies are needed regarding the harmful effects of chronic diseases as risk factors for COVID-19 infection.
DOI : 10.33448/rsd-v9i7.4840
Anahtar Kelimeler : infecções por coronavírus, epidemiologia, fatores de risco.
ISSN: 2525-3409
Cilt: 9
Sayı: 7
Sayfa: e754974840 - e754974840
46
COVID-19: A BALINESE VIEWPOINT
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Belitung Nursing Journal
Yazar(lar) :
I Gede Juanamasta , Ni Made Nopita Wati , Anak Agung Gede Oka Widana
Yıl :
2020
COVID-19: A BALINESE VIEWPOINT covid-19
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
DOI : https://doi.org/10.33546/bnj.1133
Anahtar Kelimeler : covid-19, pandemics, ceremonial behavior, meditation, diagnostic self-evaluation, public health
ISSN: 2477-4073
Cilt: 6
Sayı: 4
Sayfa: 143 - 144
Sınıflandırma :
47
Telemedicina rural e COVID-19
Dergi Makalesi

Dergi Makalesi
Open Access
Kaynak :
Directory of Open Access Journals (DOAJ)
Dergi:
Revista Brasileira de Medicina de Família e Comunidade
Yazar(lar) :
Fábio Araujo Gomes de Castro , Álisson Oliveira dos Santos , Gustavo Valadares Labanca Reis , Luara Brandão Viveiros , Mariel Hespanhol Torres , Pedro Paulo de Oliveira Junior
Yıl :
2020
Telemedicina rural e COVID-19 COVID-19.
Yayıncı Web Sitesi
 Piri Tam Metin Bulucu
Kaydet Alıntıla
Introdução: Diante da pandemia causada pelo novo coronavírus (SARS-CoV-2), evitar aglomerações e garantir o acesso aos serviços de saúde para aqueles que necessitam tem sido uma grande preocupação de profissionais e gestores. Na zona rural, as barreiras de acesso são ainda maiores. Métodos: Trata-se de relato de experiência da implantação de telemedicina via aplicativo de mensagens e chamadas por preceptor e residentes do Programa de Residência em Medicina de Família e Comunidade de Ouro Preto, em uma Unidade Básica de Saúde rural. Após três semanas da introdução da ferramenta, foi gerado manualmente um banco de dados por meio do programa Microsoft Excel® 2016, com posterior análise estatística descritiva. Resultados: No período analisado houve 329 interações por meio do WhatsApp, uma média de 25,3 pessoas por dia. Todas as demandas foram atendidas no prazo máximo de 24 horas. As teleconsultas foram realizadas nos formatos de mensagem escrita, áudios e videochamadas. A demanda para renovação de prescrições de medicamentos de uso continuado correspondeu a 20% dos atendimentos e a solicitação para análise de resultados de exames 9%. Dúvidas administrativas representaram 22% dos contatos realizados. Setenta e quatro por cento das teleconsultas foram resolvidas virtualmente e em 26% dos casos foi necessária avaliação presencial. Houve uma percepção positiva em relação à satisfação dos pacientes atendidos virtualmente, de acordo com os relatos dos Agentes Comunitários de Saúde e por meio de mensagens recebidas diretamente pela equipe médica pelo aplicativo. Conclusão: O uso de aplicativo de mensagens e chamadas, como ferramenta de telemedicina, mostrou ser uma estratégia viável durante a pandemia de SARS-CoV-2, especialmente importante no meio rural. Outros estudos serão necessários para investigar seus impactos no sistema de saúde e nos desfechos relevantes para a população.
DOI : 10.5712/rbmfc15(42)2484
Anahtar Kelimeler : Telemedicina, Saúde da População Rural, Medicina de Família e Comunidade, Atenção Primária à Saúde, COVID-19.
Cilt: 15
Sayı: 42

Yayın Yılı

Sınırla

Doküman Türü
Tümü

Veri Tabanı
Tümü

Dergi İsmi
Tümü

Disiplin
Tümü

Disipline Göre İlgililik

Alt Disiplin
Tümü

Konu
Tümü

Yayıncı
Tümü

Lisan
Tümü

X
Filtreler